Skip to content

3D Printed Models in Mohs Micrographic Surgery

The Use of 3D Printed Models in Mohs Micrographic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03461965
Enrollment
82
Registered
2018-03-12
Start date
2018-03-02
Completion date
2019-01-25
Last updated
2021-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mohs Micrographic Surgery

Keywords

3D printing, Patient education

Brief summary

Patients undergoing Mohs micrographic surgery (MMS) frequently experience anxiety. It has been suggested that enhanced patient education prior to the procedure may decrease patient anxiety. The purpose of the study is to investigate if optimized participant education enhances participant understanding, decreases participant anxiety and increases participant satisfaction.

Detailed description

1. To investigate if participant education with a 3 dimensional printed (3DP) MMS model and standardized script protocol increases participant understanding of MMS more than current standard of care (control group) at the University Hospitals Cleveland Medical Center MMS Clinics. 2. To investigate if participant education with a 3DP MMS model and standardized script protocol decreases perioperative participant anxiety during MMS more than current standard of care (control group) at the University Hospitals Cleveland Medical Center MMS Clinics. 3. To evaluate if participant satisfaction with a 3DP MMS model and standardized script protocol increases participant satisfaction during MMS more than current standard of care (control group) at the University Hospitals Cleveland Medical Center MMS Clinics.

Interventions

A printed 3D model of MMS will be created showing a model of skin, and a tumor to visually depict the surgery

BEHAVIORALVerbal Counselling

Participants will be educated with a standardized script on skin cancer, risks for skin cancer, treatment options, and MMS

Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
CollaboratorNIH
Case Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Patients will be recruited from University Hospitals Department of Dermatology MMS Clinics at the Cleveland Medical Center, Chagrin Highlands and Westlake Locations. These patients will be randomly assigned to a control (50%) or experimental group (50%) prior to the onset of the study protocol.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing MMS at University Hospitals Cleveland Medical Center, Chagrin Highlands and Westlake Campus * Capable of reading and completing all subjective questionnaires

Exclusion criteria

* Cannot complete the survey measures independently for any reason

Design outcomes

Primary

MeasureTime frameDescription
Percent of Correct and Incorrect Mohs Quiz ResponsesPost surgery (1 day)This is an in-house-designed, short questionnaire with 6 multiple choice objective questions related to the participant's understanding of Mohs. A higher percentage of correct answers indicate a better understanding of Mohs. Reported data are percent of responses answered correctly and incorrectly totaled across all participants in each arm

Secondary

MeasureTime frameDescription
Change in State-Trait Anxiety Inventory (STAI) Y-1 (State Anxiety) ScoreFrom baseline to post surgery (1 day)The STAI is a well-known, frequently used measure of patient anxiety within the clinical setting. This form consists of two forms to assess state anxiety (Y-1) and a participant's baseline trait anxiety (Y-2). The Y-1 form consists of 20 Likert-type questions with scores ranging from 20 to 80, with higher scores indicating higher anxiety. Reported values are change in state anxiety' (post-stage minus baseline)
Change in Visual Analog Scale (VAS) Anxiety ScoreFrom baseline to post surgery (1 day)The VAS is a frequently employed Likert-type scale that is used to measure anxiety. This 0-10 scale documents the patients current state of anxiety, with higher scores indicating worse anxietey, and can be answered by patients with an average reading level. Estimated time of completion is under 30 seconds. This form has been used in 2 studies to date and previously by experimental team to assess intraoperative anxiety in Mohs.
Change in Visual Analog Scale (VAS) Understanding ScoreFrom baseline to post surgery (1 day)The VAS is a frequently employed Likert-type scale that because of the ease of use this tool has been converted to assess other objective measures including understanding. This 0-10 scale documents the participant's current state of understanding, with higher scores indicating better understanding, and can be answered by patients with an average reading level. Estimated time of completion is under 30 seconds. This form has been used by experimental team to assess intraoperative understanding in Mohs.
Satisfaction Survey ScorePost surgery (1 day)Participants were provided 3 subjective questions related to their satisfaction with the explanation of MMS that they received. This scale included questions regarding satisfaction with their explanation of the MMS procedure, if the explanation used could be improved, and if they recommended other patients be provided a similar explanation of MMS, with each question scored from 1 to 5, with higher scores indicating greater satisfaction. Total score range is 0 to 15, with higher scores indicating greater satisfaction.

Countries

United States

Participant flow

Participants by arm

ArmCount
Education With 3D Printed Model
The experimental group will be educated on MMS with a standardized script in addition to a 3D MMS model 3D printed model: A printed 3D model of Mohs Micrographic Surgery will be created showing a model of skin, and a tumor to visually depict the surgery Verbal Counselling: patients will be educated with a standardized script on skin cancer, risks for skin cancer, treatment options, and Mohs Micrographic Surgery Participants in the control group will be educated on MMS according to the current standard of care, verbal counselling, with a standardized script Verbal Counselling: patients will be educated with a standardized script on skin cancer, risks for skin cancer, treatment options, and Mohs Micrographic Surgery
42
Verbal Counselling
Participants in the control group will be educated on MMS according to the current standard of care, verbal counselling, with a standardized script Verbal Counselling: patients will be educated with a standardized script on skin cancer, risks for skin cancer, treatment options, and Mohs Micrographic Surgery
40
Total82

Baseline characteristics

CharacteristicEducation With 3D Printed ModelVerbal CounsellingTotal
Age, Continuous67.83 Years
STANDARD_DEVIATION 11.34
67.83 Years
STANDARD_DEVIATION 12.89
67.83 Years
STANDARD_DEVIATION 12.1
Baseline STAI Y-2 Trait Anxiety29.8 units on a scale
STANDARD_DEVIATION 7.53
31.1 units on a scale
STANDARD_DEVIATION 8.85
30.5 units on a scale
STANDARD_DEVIATION 8.25
Previous MMS experience
Mohs Experience
20 Participants19 Participants39 Participants
Previous MMS experience
No Mohs Experience
22 Participants21 Participants43 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
42 participants40 participants82 participants
Sex: Female, Male
Female
18 Participants15 Participants33 Participants
Sex: Female, Male
Male
24 Participants25 Participants49 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Percent of Correct and Incorrect Mohs Quiz Responses

This is an in-house-designed, short questionnaire with 6 multiple choice objective questions related to the participant's understanding of Mohs. A higher percentage of correct answers indicate a better understanding of Mohs. Reported data are percent of responses answered correctly and incorrectly totaled across all participants in each arm

Time frame: Post surgery (1 day)

ArmMeasureGroupValue (NUMBER)
Education With 3D Printed ModelPercent of Correct and Incorrect Mohs Quiz ResponsesCorrect Quiz Responses93.25 Percent of quiz responses
Education With 3D Printed ModelPercent of Correct and Incorrect Mohs Quiz ResponsesIncorrect Quiz Responses6.75 Percent of quiz responses
Verbal CounsellingPercent of Correct and Incorrect Mohs Quiz ResponsesIncorrect Quiz Responses14.17 Percent of quiz responses
Verbal CounsellingPercent of Correct and Incorrect Mohs Quiz ResponsesCorrect Quiz Responses85.83 Percent of quiz responses
Comparison: Comparing total responses that were correct across all participants in both armsp-value: 0.007t-test, 2 sided
Secondary

Change in State-Trait Anxiety Inventory (STAI) Y-1 (State Anxiety) Score

The STAI is a well-known, frequently used measure of patient anxiety within the clinical setting. This form consists of two forms to assess state anxiety (Y-1) and a participant's baseline trait anxiety (Y-2). The Y-1 form consists of 20 Likert-type questions with scores ranging from 20 to 80, with higher scores indicating higher anxiety. Reported values are change in state anxiety' (post-stage minus baseline)

Time frame: From baseline to post surgery (1 day)

ArmMeasureValue (MEAN)Dispersion
Education With 3D Printed ModelChange in State-Trait Anxiety Inventory (STAI) Y-1 (State Anxiety) Score-4.95 Score on a scaleStandard Deviation 6.95
Verbal CounsellingChange in State-Trait Anxiety Inventory (STAI) Y-1 (State Anxiety) Score-3.3 Score on a scaleStandard Deviation 9.37
Comparison: Difference of pre (baseline) and post-test scores within each treatment groupp-value: 0.0001t-test, 2 sided
Comparison: Difference of pre (baseline) and post-test scores within each treatment groupp-value: <0.03t-test, 2 sided
Comparison: Comparing change in scores (post-stage minus baseline) between experimental and control groupsp-value: 0.352t-test, 2 sided
Secondary

Change in Visual Analog Scale (VAS) Anxiety Score

The VAS is a frequently employed Likert-type scale that is used to measure anxiety. This 0-10 scale documents the patients current state of anxiety, with higher scores indicating worse anxietey, and can be answered by patients with an average reading level. Estimated time of completion is under 30 seconds. This form has been used in 2 studies to date and previously by experimental team to assess intraoperative anxiety in Mohs.

Time frame: From baseline to post surgery (1 day)

ArmMeasureValue (MEAN)Dispersion
Education With 3D Printed ModelChange in Visual Analog Scale (VAS) Anxiety Score-1.31 Score on a scaleStandard Deviation 2
Verbal CounsellingChange in Visual Analog Scale (VAS) Anxiety Score-0.53 Score on a scaleStandard Deviation 1.54
Comparison: Difference of pre (baseline) and post-test scores within each treatment groupp-value: <0.0001t-test, 2 sided
Comparison: Difference of pre (baseline) and post-test scores within each treatment groupp-value: 0.04t-test, 2 sided
Comparison: Comparing change in scores (post-stage minus baseline) between experimental and control groupsp-value: 0.052t-test, 2 sided
Secondary

Change in Visual Analog Scale (VAS) Understanding Score

The VAS is a frequently employed Likert-type scale that because of the ease of use this tool has been converted to assess other objective measures including understanding. This 0-10 scale documents the participant's current state of understanding, with higher scores indicating better understanding, and can be answered by patients with an average reading level. Estimated time of completion is under 30 seconds. This form has been used by experimental team to assess intraoperative understanding in Mohs.

Time frame: From baseline to post surgery (1 day)

ArmMeasureValue (MEAN)Dispersion
Education With 3D Printed ModelChange in Visual Analog Scale (VAS) Understanding Score1.83 Score on a scaleStandard Deviation 2.22
Verbal CounsellingChange in Visual Analog Scale (VAS) Understanding Score2.46 Score on a scaleStandard Deviation 2.34
Comparison: Difference of pre (baseline) and post-test scores within each treatment groupp-value: <0.0001t-test, 2 sided
Comparison: Difference of pre (baseline) and post-test scores within each treatment groupp-value: <0.0001t-test, 2 sided
Comparison: Comparing change in scores (post-stage minus baseline) between experimental and control groupsp-value: 0.208t-test, 2 sided
Secondary

Satisfaction Survey Score

Participants were provided 3 subjective questions related to their satisfaction with the explanation of MMS that they received. This scale included questions regarding satisfaction with their explanation of the MMS procedure, if the explanation used could be improved, and if they recommended other patients be provided a similar explanation of MMS, with each question scored from 1 to 5, with higher scores indicating greater satisfaction. Total score range is 0 to 15, with higher scores indicating greater satisfaction.

Time frame: Post surgery (1 day)

ArmMeasureValue (MEAN)Dispersion
Education With 3D Printed ModelSatisfaction Survey Score14.69 score on a scaleStandard Deviation 0.811
Verbal CounsellingSatisfaction Survey Score13.58 score on a scaleStandard Deviation 1.599
p-value: <0.03Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026